"Designing Growth Strategies is in our DNA"
Region : Global | Published Date: Upcoming | Report ID: FBI100602| Status : Upcoming
With an increasing number of open and minimally invasive procedures globally, there is a high adoption and demand for the ultrasonic dissection devices, due to their clinical effectiveness during the surgical procedure and surgeon preference. Ultrasonic dissection devices are surgical hand-held devices used in open and laparoscopic surgery for soft tissue dissection and vessel blockage. Ultrasonic devices have a low risk of collateral destruction. The ultrasonic devices consist of a piezoelectric transducer to generate ultrasonic waves and a scalpel to cut and coagulate the tissue. These devices use ultrasonic energy to cut, coagulate and seal the tissue or vessel. Ultrasonic dissection has recently gained traction owing to certain clinical benefits of ultrasonic energy over electrosurgeries, such as the reduced lateral spread of thermal energy leading to reduced damage to surrounding tissues and vessels, and reduced or minimized smoke generation, enabling healthcare providers and surgeons to perform efficient surgical procedures.
Rise in incidence of chronic diseases globally is presenting a large patient pool undergoing open and minimally invasive surgical procedures. Minimally invasive surgery has been one of the most preferred methods of treatment and has hug demand globally. This has led to an increase in the usage of ultrasonic dissection devices for performing these surgeries. These are some of the factors anticipated to drive the growth of the global ultrasonic dissection devices market. Additionally, increased adoption of robotic surgical procedures and various befinits of ultrasonic dissection devices over the conventional electrosurgical methods are some of the factors driving the growth of the global ultrasonic dissection devices market. According to the American Congress of Obstetricians and Gynecologists (ACOG), there is a massive increase in the minimally invasive hysterectomy procedures performed in the U.S., from an estimated 14% in 2004 to 53% in 2013. This is anticipated to drive the growth of the global ultrasonic dissection devices market during the forecast period of 2019-2026.
To get information on various segments, share your queries with us
The high cost of the ultrasonic devices over the currently available electrosurgery devices is a major factor restraining the growth of the global ultrasonic dissection devices market during the forecast period.
Some of the major companies that are present in the global ultrasonic dissection devices market are Ethicon USA, LLC., InnoSound Technologies, Inc., Söring GmbH, Reach Surgical, Medtronic, Misonix, BOWA-electronic GmbH & Co. KG, TransEnterix, Inc., and others.
· Hand-held devices
· Ultrasonic Generators
· General Surgery
· Plastic surgery
By End User
· Specialty Clinics
· Ambulatory Surgery Centres
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Among the products, hand held devices accounted for the largest share of the global ultrasonic dissection devices market in 2018, owing to the increasing preference of healthcare providers towards disposable hand-held devices and new and innovative devices being introduced in the global market.
Reimbursement Scenario for key countries
Pricing Analysis by Key Regions
Recent industry developments such as partnerships, mergers, and acquisitions
North America accounted for the largest share of the global ultrasonic dissection devices market in 2017, owing to the increasing adoption of the ultrasonic devices, increase in the number of approvals for new devices in the market, and growing shift of healthcare providers towards minimally invasive surgeries. Asia-Pacific and Latin America regions are expected to register comparatively higher CAGR over the forecast period, owing to factors such as increasing shift in emerging countries towards minimally invasive surgical procedures, and clinical benefits of ultrasonic devices in minimally invasive surgical procedures, leading to higher preference for these devices by surgeons and healthcare providers.
Key Industry Developments
· In January 2019, TransEnterix, Inc., received FDA clearance for its Senhance Ultrasonic System. Since 2000, Senhance System is the first new abdominal robotic surgery platform to receive FDA clearance. It is the first and only digital laparoscopic surgical platform to offer the security of haptic force feedback that allows surgeons to feel the forces generated by instrument while handling the delicate tissue.
· In October 2017, Single Use Surgical, launched single-use Diathermy Abbey needle with suction that helps surgeons improve performance and outcomes during various procedures.